(Alliance News) - Unilever PLC on Monday said Chief Executive Alan Jope will step down at the end of next year, after five years in the post. Read More
(Alliance News) - All eyes will be on the pound when traders in Europe return to desks on Monday, after the UK currency fell to an all-time low during the Asian session. Read More
(Alliance News) - GSK PLC on Thursday said its cancer drug Zejula will be reviewed by the US Food & Drug Administration for overall survival data for patients with ovarian cancer. Read More
(Alliance News) - GSK PLC on Thursday said it has signed an exclusive licence agreement with Massachusetts-based biotechnology firm Spero Therapeutics for the latter's tebipenem pivoxil hydrobromide, or tebipenem HBr. Read More
(Alliance News) - Haleon PLC on Tuesday reported a strong performance in the first half of 2022 in its first earnings report since being split from GSK PLC in July and separately listed, noting double-digit revenue growth and profit rise. Read More
(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More
(Alliance News) - AstraZeneca PLC on Friday said it received two recommendations for drug approvals in the EU, while a drug for blood disorder paroxysmal nocturnal haemoglobinuria met its primary endpoint in a phase three trial. Read More
(Alliance News) - GSK PLC on Friday said niraparib, sold under the brand name Zejula, has shown long-term survival benefit in an ovarian cancer study. Read More
(Alliance News) - GSK PLC on Tuesday said the World Health Organisation made it easier for its malaria vaccine Mosquirix to be rolled out while the US Food & Drug Administration is reviewing the firm's kidney disease drug, daprodustat. Read More
(Alliance News) - Biopharma firm GSK PLC on Thursday said it will present new data on its ovarian cancer and endometrial cancer drugs from September 9 to 13 at the European Society for Medical Oncology Congress 2022 in Paris. Read More
(Alliance News) - The FTSE 100 managed to outperform European counterparts on Friday due to weakness in the pound as consumer confidence in the UK fell to a record low, while attention turns to next week's Jackson Hole Symposium. Read More
(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade. Read More
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has accepted the new drug application for its momelotinib, which could potentially treat a rare blood cancer myelofibrosis. Read More
